Pharmaceuticals, Biotechnology and Life Sciences
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol-Myers Squibb Company (NYSE: BMY) today announced five-year follow-up results from the Phase 3 CheckMate -025 study,…
Updated results from CheckMate -214 study show that more than 50% of patients treated with Opdivo plus Yervoy were alive…
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the HIV therapeutics market and it is poised to grow by USD 2.44 billion during…
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the proteinuria therapeutics market and it is poised to grow by USD 81.83 million during…
LONDON–(BUSINESS WIRE)–#Healthcare–Technavio has been monitoring the west Nile virus therapeutics market and it is poised to grow by USD 23.46…
DUBLIN–(BUSINESS WIRE)–The “DiaCarta Inc – Product Pipeline Analysis, 2019 Update” company profile has been added to ResearchAndMarkets.com’s offering. Summary DiaCarta…
Democratic Republic of the Congo One of the First African Countries to Register ERVEBO KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK),…
– New data from the VISIBLE 2 trial presented at the 15th Congress of the European Crohn’s and Colitis Organisation…
DUBLIN–(BUSINESS WIRE)–The “Dilated Cardiomyopathy – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides…
SYDNEY–(BUSINESS WIRE)–#GU20—Noxopharm (ASX: NOX) is pleased to announce positive interim results from its LuPIN Phase 1/2 clinical trial. The data…